|
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
RECRUITINGSponsored by AstraZeneca
Actively Recruiting
SponsorAstraZeneca
Started2025-08-20
Est. completion2027-09-30
Eligibility
Age18 Years – 130 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07143110
Summary
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Eligibility
Age: 18 Years – 130 YearsHealthy volunteers accepted
Inclusion Criteria: * Patients with lung cancer between January 1, 2018 and end of the Selection Period. * Patient is 18 years of age or older on diagnosis date. * Patient has at least 12 months of health insurance coverage prior to the diagnosis date. Exclusion Criteria: * Diagnosed with any other cancer in the 5-year period prior to January 1, 2018. * Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis. * Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type). * Non-Ontario or non-Alberta resident on diagnosis date.
Conditions3
CancerLung CancerLung Neoplasms
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorAstraZeneca
Started2025-08-20
Est. completion2027-09-30
Eligibility
Age18 Years – 130 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07143110